Latest market price
13.65
-0.50-3.53%
OverviewShort InterestFilings
SNDXQT31Syndax Pharmaceuticals, Inc.·NASDAQ
13.65-3.53%

Latest SEC Filings

Form category
DescriptionFilingDocument
Oct 30, 20264Statement of changes in beneficial ownership
Aug 07, 2026SC 13GBeneficial ownership statement (passive)
Aug 04, 20268-KCurrent report
Aug 04, 202610-QQuarterly report
Jul 14, 20268-KCurrent report
Jul 09, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 10, 20268-KCurrent report
Jun 10, 20268-KCurrent report
Jun 04, 2026DEFA14AAdditional proxy soliciting materials
Jun 04, 20268-KCurrent report
Jun 02, 20264Statement of changes in beneficial ownership
Jun 02, 20264Statement of changes in beneficial ownership
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Apr 30, 2026SC 13GBeneficial ownership statement (passive)
Apr 30, 2026DEF 14ADefinitive proxy statement
Apr 30, 20268-KCurrent report
Apr 30, 2026DEFA14AAdditional proxy soliciting materials
Apr 30, 202610-QQuarterly report
Apr 30, 2026ARSAnnual report to shareholders
Mar 27, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Feb 26, 20268-KCurrent report
Feb 26, 2026S-8Registration of employee benefit securities
Feb 26, 202610-KAnnual report
Feb 10, 20264Statement of changes in beneficial ownership
#1 / 25 of 286
Page
▼
/ 12